Tempus AI：数据与应用将释放更多上行空间（纳斯达克：TEM）
· seekingalpha.com
Tempus AI 第二季度肿瘤检测量同比增长31%，自2025年第四季度以来MRD检测量几乎翻倍。了解为何TEM股票值得买入。
Back in July, I provided an update on Tempus AI, Inc. ( TEM ) after their Personalis ( PSNL ) acquisition announcement. Despite being a little expensive, I view...